ribose in English

noun
1
a sugar of the pentose class that occurs widely in nature as a constituent of nucleosides and several vitamins and enzymes.
In undiluted samples, ribose , fructose, rhamnose, glucose, and one unidentified sugar were detected at low concentrations (data not shown).

Use "ribose" in a sentence

Below are sample sentences containing the word "ribose" from the English Dictionary. We can refer to these sentence patterns for sentences in case of finding sample sentences with the word "ribose", or refer to the context using the word "ribose" in the English Dictionary.

1. Adenine combined with ribose produces the nucleoside adenosine

2. Adenine and ribose alone or together are ineffective. — 3.

3. Adenine nucleotides in RBCs contain Adenine, ribose, and one or more phosphate groups

4. The latter form is predominant (whereas the C3′-endo form is favored for ribose).

5. Adenine (Anitrogenous ase) ribose (a five carbon sugar) three phosphate groups

6. Adenosine definition, a white, crystalline, water-soluble nucleoside, C10H13N5O4, of adenine and ribose

7. Acid hydrolysis of the alga afforded galactose, glucose, xylose, ribose and glucuronic acid.

8. Concentrative influx of functionally active cyclic ADP-ribose in dimethyl sulfoxide-differentiated HL-60 cells

9. A general method for the photochemical generation of ribose Abasic sites within RNA oligonucleotides is reported

10. Furthermore, poly(ADP-ribose) polymerase (PARP) inhibitors could further expand the treatment options for recurrent disease.

11. Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage

12. Mannose 6-phosphate isomerase mutant derived from geobacillus thermodenitrificans, and production method of l-ribose using same

13. Adenosine (Adenine with a ribose group) causes transient heart block in the AV node of the heart

14. An inhibitory effect was also observed for the uptake of labelled adenosine, uridine, hypoxanthine, and adenine, but not for ribose.

15. Anti-PARP1 (Cleaved form) Antibody from rabbit, purified by affinity chromatography; Synonym: Poly [ADP-ribose] polymerase 1, PARP-1, NAD(+) ADP-ribosyltransferase 1, ADPRT 1, Poly[ADP-ribose] synthase 1, ARTD1; find Sigma-Aldrich-ABC26 MSDS, related peer-reviewed papers, technical documents, similar products & more at Sigma-Aldrich.

16. Ribose was isolated from RNA and fermented by Lactobacillus plantarum with the production of acetic and lactic acids.

17. Adenosine is a ribonucleoside that is composed of adenine bound to ribose with vasodilatory, antiarrhythmic and analgesic activities

18. The acetolysis-inversion reaction has been carried out with 2,3;5,6-di-O-isopropylidene-D-gulofuranose, 2,3;6,7-di-O-isopropylidene-D-glycero-D-gulo-heptose, 2,3-O-isopropylidene-D-ribose, D-ribose, and D-mannose using chromatography for isolation of the deacetylated epimeric products.

19. Adenine is essential for many in vivo and in vitro biochemical processes. Adenine is converted to adenosine with ribose

20. Adenosine (plural Adenosines) (biochemistry, genetics, organic chemistry) A nucleoside derived from adenine and ribose, found in striated muscle tissue

21. Irradiation of the modified RNA at 350 nm efficiently produced ribose Abasic sites at specific sites within RNA sequences

22. Adenosine definition is - a nucleoside C10H13N5O4 that is a constituent of RNA and yields adenine and ribose on hydrolysis.

23. Adenosine is the larger nucleotide molecule made up of Adenine, ribose or deoxyribose, and one or more phosphate groups.

24. The first to be identified was the use of NAD+ as the ADP-ribose donor in ADP-ribosylation reactions, observed in the early 1960s.

25. What does the Atp structure look like? squared box that is a combination of adenine and ribose which is called adenosine

26. Electron donor and electron acceptor moieties are covalently bound to the ribose-phosphate backbone of a nucleic acid at predetermined positions.

27. Inhibitors of poly(ADP-ribose)polymerase having a structure of Formula (I), ways to make them and methods of treating patients using them are disclosed.

28. Studies in the 1980s and 1990s revealed the activities of NAD+ and NADP+ metabolites in cell signaling – such as the action of cyclic ADP-ribose, which was discovered in 1987.

29. It was found that bo th the growth pattern and the production of D-ribose were changed with the concentration of corn steep liqor in the media.

30. The poly(ADP-ribose) structure is involved in the regulation of several cellular events and is most important in the cell nucleus, in processes such as DNA repair and telomere maintenance.

31. Cytosar, Udicil, Alexan, Cytarbel, Aracytin, Erpalfa, Aracytine, Arabine, TArabine Pfs, Cytosar-U, and Ara-Cell NCI Definition : An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose)

32. ADP-ribosyl cyclase: an enzyme that Cyclizes NAD+ into a calcium-mobilizing metabolite Cyclic ADP-ribose (cADPR) is a metabolite of NAD+ that is as active as inositol trisphosphate (IP3) in mobilizing intracellular Ca2+ in sea urchin eggs.

33. In the presence of allopurinol, apparent phosphoribosylpyrophosphate (PP-ribose-P) availability as measured by adenine incorporation into ribonucleotides was decreased in rat liver cells, hypoxanthine incorporation into ribonucleotides was increased, and there was a large synthesis of inosine from hypoxanthine.

34. I n my essay “Animadversions of a Synthetic Chemist,” I wrote that, “The coupling of a ribose with a nucleotide is the first step [in abiogenesis], and even those engrossed in prebiotic research have difficulty envisioning that process, especially for purines and pyrimidines.” 1 Thomas Carell’s group has accomplished that coupling

35. Adenine + 5-phospho-alpha-D-ribose 1-diphosphate -> AMP + diphosphate PlantCyc Adenine: Adenine + Adenine + H2O + H+ + H+ + H2O -> hypoxanthine + ammonium + ammonium + hypoxanthine PlantCyc Adenine: Adenine + H+ + H2O -> ammonium + hypoxanthine PlantCyc Adenine: Adenine is a purine derivative and a nucleobase with a variety of roles in

36. The molecule consists of an Adenine attached to a ribose via a β-N 9-glycosidic bond.Adenosine is one of four nucleoside building blocks to DNA and RNA, which are essential for all life.Its derivatives include the energy carriers adenosine mono-, di-, and triphosphate, also known as AMP/ADP/ATP.

37. The sub-units are called nucleotides<br />Each nucleotide is made up of <br />a pentose sugar called ribose<br />a phosphate group -PO4 and<br />Anitrogenous base<br />RNA is a large molecule made up of a long chain of sub-units<br />*RNA structure: single-strand molecule<br />Note: Backbone consists of alternating P-S-P-S-P- etc…<br /> 84.

38. A compound of the formula (I):whereinring A is a carbocyclic group, R1 is hydrogen or a halogen atom or a lower alkyl group,R2 is a di(lower)alkylamino group or N-containing heterocyclic group, among which the N-containing heterocyclic group may be substituted with one or more substituent(s),Y is an oxygen or sulfur atom, n is an integer from 0 to 2, andm is an integer from 0 to 4,or its prodrug, or their salt.which has poly(adenosine 5'-diphospho-ribose)polymerase inhibiting activity.

39. The present invention relates to a pharmaceutical composition for treating chronic myeloid leukemia, containing a Liriodendron tulipifera L. bark extract as an active ingredient, and more specifically, to a pharmaceutical composition for treating chronic myeloid leukemia, containing a Liriodendron tulipifera L. bark extract, which causes cell death by a change in mitochondrial membrane potential (MMP) in leukemia cells, and the cleavage of poly(ADP-ribose) polymerase (PARP) and caspase-3 related to a cell death pathway, in order to selectively inhibit the T315I mutant enzyme generated by the mutation of the BCR-ABL fusion gene, which is a gene causing chronic myeloid leukemia.

40. The present invention relates to a pharmaceutical dosage form for treating chronic myeloid leukemia, containing a Liriodendron tulipifera L. bark extract as an active ingredient, and more specifically, to a pharmaceutical dosage form for treating chronic myeloid leukemia, containing a Liriodendron tulipifera L. bark extract, which causes cell death by a change in mitochondrial membrane potential (MMP) in leukemia cells and the cleavage of poly(ADP-ribose) polymerase (PARP) and caspase-3 related to a cell death pathway, in order to selectively inhibit the T315I mutant enzyme generated by the mutation of the BCR-ABL fusion gene, which is a gene causing chronic myeloid leukemia.